India and Uzbekistan launch pharma-nutra corridor targeting $7–10 billion Eurasian market

Exam-focused facts from the 11 March 2026 current affairs briefing.

Key facts

India and Uzbekistan launched a structured pharmaceutical and nutraceutical trade corridor on Monday.
The corridor is backed by Uzbekistan’s Ministry of Health, Nutrify Today, and Pharma Eurasia.
It aims to improve regulatory alignment, investment, and market entry for manufacturers targeting the $7–10 billion Eurasian healthcare market.
Uzbekistan is positioning itself as a regional gateway through policy reforms, dedicated pharma parks, and investment facilitation.
The corridor’s commercial execution will take place at Pharma Eurasia 2026 in Tashkent from May 20 to 22.
The CIS dietary supplements market is estimated at over $5.8 billion annually.